GlassScriptPhysician profile
Gerald D Luciani
NPI 1295791069
$9,387.01
in general payments reported to CMS, 2019-2025
36 companies · $4,669 in 2025
The $4,669 reported for 2025 was more than what 97% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $418 · 2020: $241 · 2021: $574 · 2022: $715 · 2023: $431 · 2024: $2,339 · 2025: $4,669.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,600 · Food and Beverage: $839.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,600.00 |
| Food and Beverage | $838.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $6,600.00 | 2024-2025 | Bovine Collagen |
| Abbvie INC. | $761.51 | 2019-2023 | |
| Exeltis, USA INC. | $306.67 | 2019-2024 | Slynd |
| Organon LLC | $150.56 | 2021-2025 | Nexplanon |
| Aspira Women'S Health INC | $129.29 | 2021-2023 | Ova1 |
| Millicent US INC | $118.30 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $111.75 | 2019-2022 | |
| Sage Therapeutics, LLC | $105.13 | 2024-2025 | Zurzuvae |
| Lupin INC. | $98.40 | 2019-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $86.45 | 2022 | |
| Astellas Pharma US INC | $83.04 | 2023-2025 | Veozah, Myrbetriq |
| Innovation Technologies INC | $82.23 | 2023 | Irrisept |
| Myovant Sciences INC. | $61.81 | 2021 | |
| Pfizer INC. | $58.86 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $47.37 | 2019-2020 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $43.86 | 2021-2022 | |
| Molnlycke Health Care US, LLC | $42.08 | 2024 | Mepilex Border Post-Op, Avance, Mepilex Border Post-Op Ag |
| Abiomed | $42.01 | 2024 | Impella |
| Coopersurgical, INC. | $41.93 | 2020-2022 | |
| Abbott Laboratories | $37.02 | 2023 | Proclaim, Jot Dx |
| Avanos Medical | $36.57 | 2019-2021 | |
| Agile Therapeutics, INC. | $35.02 | 2021 | |
| Mission Pharmacal Company | $33.97 | 2019-2020 | |
| Allergan, INC. | $32.56 | 2020 | |
| Minerva Surgical, INC | $29.75 | 2021-2022 | |
| Hologic Sales and Service, LLC | $27.48 | 2019-2022 | |
| Pacira Pharmaceuticals Incorporated | $26.08 | 2025 | Exparel |
| Meditrina | $23.86 | 2021 | |
| Amag Pharmaceuticals, INC. | $22.87 | 2019 | |
| Genzyme Corporation | $22.43 | 2023 | |
| Duchesnay USA Incorporated | $15.48 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $15.40 | 2021 | |
| Acessa Health INC. | $14.65 | 2021 | |
| Conmed Corporation | $14.64 | 2025 | Airseal |
| Cumberland Pharmaceuticals, INC. | $14.07 | 2019 | |
| Boston Scientific Corporation | $13.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerald Luciani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.